Try The Drug Club risk-free for 30 days Trial terms

Trimethoprim — Membership Pricing

Trimethoprim is not confirmed for no-additional-cost pricing. Membership pricing may be available; confirm the price with the dispensing pharmacy.

Trimethoprim Pricing

Pricing typePrice
TheDrugClubMembership pricing may be available
Typical Retail$89.99

Membership pricing may be available; confirm the price with the dispensing pharmacy.

About Trimethoprim

Trimethoprim is a prescription medication. Ask your doctor if Trimethoprim is right for you.

Combination products containing Trimethoprim

Conditions Treated with Trimethoprim

How to Check Trimethoprim Pricing

  1. Join TheDrugClub for $19.95/month
  2. Receive your member card by email
  3. Present your card at a participating pharmacy
  4. Check active-formulary eligibility or available membership pricing

Trimethoprim at Participating Pharmacies

Pharmacy participation and fulfillment options vary. Present your membership card and confirm current pricing before filling.

Related medications

Other medications associated with the same conditions in this catalog.

Also listed for Urinary Tract Infection

Other medications in Infectious Disease

What Trimethoprim is approved for (FDA label)

For the treatment of initial episodes of uncomplicated urinary tract infections due to susceptible strains of the following organisms: Escherichia coli , Proteus mirabilis , Klebsiella pneumoniae , Enterobacter species, and coagulase-negative Staphylococcus species, including S. saprophyticus . Cultures and susceptibility tests should be performed to determine the susceptibility of the bacteria to trimethoprim. Therapy may be initiated prior to obtaining the results of these tests.

Source: Read the full FDA label on DailyMed. Label effective date: June 4, 2024.

Excerpt from the FDA-approved prescribing information. This is not medical advice; talk to your doctor or pharmacist.

Adverse reactions for Trimethoprim (FDA label)

The adverse effects encountered most often with trimethoprim were rash and pruritus. Dermatologic Rash, pruritus, and phototoxic skin eruptions. At the recommended dosage regimens of 100 mg b.i.d. or 200 mg q.d., each for 10 days, the incidence of rash is 2.9% to 6.7%. In clinical studies which employed high doses of trimethoprim, an elevated incidence of rash was noted. These rashes were maculopapular, morbilliform, pruritic, and generally mild to moderate, appearing 7 to 14 days after the initiation of therapy. Hypersensitivity Rare reports of exfoliative dermatitis, erythema multiforme, Stevens-Johnson syndrome, toxic epidermal necrolysis (Lyell Syndrome), and anaphylaxis have been received. Gastrointestinal Epigastric distress, nausea, vomiting, and glossitis.

Source: FDA prescribing information (DailyMed). Set ID: 249e938d-f181-47c4-a082-372d65462f33. SPL document ID: 6a57562b-424f-40ef-9b86-fa0e66c1c344. Label effective date: June 4, 2024. Read the full label.

Excerpt from the FDA-approved prescribing information. This is not medical advice; talk to your doctor or pharmacist.

Contraindications for Trimethoprim (FDA label)

Trimethoprim is contraindicated in individuals hypersensitive to trimethoprim and in those with documented megaloblastic anemia due to folate deficiency.

Source: FDA prescribing information (DailyMed). Set ID: 249e938d-f181-47c4-a082-372d65462f33. SPL document ID: 6a57562b-424f-40ef-9b86-fa0e66c1c344. Label effective date: June 4, 2024. Read the full label.

Excerpt from the FDA-approved prescribing information. This is not medical advice; talk to your doctor or pharmacist.

Drug interactions for Trimethoprim (FDA label)

Trimethoprim may inhibit the hepatic metabolism of phenytoin. Trimethoprim, given at a common clinical dosage, increased the phenytoin half-life by 51% and decreased the phenytoin metabolic clearance rate by 30%. When administering these drugs concurrently, one should be alert for possible excessive phenytoin effect.

Source: FDA prescribing information (DailyMed). Set ID: 249e938d-f181-47c4-a082-372d65462f33. SPL document ID: 6a57562b-424f-40ef-9b86-fa0e66c1c344. Label effective date: June 4, 2024. Read the full label.

Excerpt from the FDA-approved prescribing information. This is not medical advice; talk to your doctor or pharmacist.

Start Your Risk-Free Trial
Start Your Risk-Free Trial